• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1994 Fiscal Year Final Research Report Summary

Study for the role of proteoglycans during tissue repair after acute liver injury

Research Project

Project/Area Number 05670476
Research Category

Grant-in-Aid for General Scientific Research (C)

Allocation TypeSingle-year Grants
Research Field Gastroenterology
Research InstitutionOkayama University

Principal Investigator

KOIDE Norio  Okayama University, University Hospital, Lecturer, 医学部・付属病院, 講師 (20142333)

Project Period (FY) 1993 – 1994
KeywordsExtracellular matrix / D-gal liver injury / proteoglycan / decorin / biglycan / fibroglycan
Research Abstract

We investigated the role of proteoglycans (PG) during tissue repair after acute liver injury induced to rats by the administration of D-galactosamine. By immunohistochemical study using anti-heparansulfate antibodies and anti DELTAdi antibodies both heparansulfate-PGs and chondroitin sulfate PGs transiently changed in the early phase of acute liver injury.Heparansulfate-PGs transiently disappeared form hepatocyte at 6h after the initiation of acute liver injury and chondroitinsufate PGs increased in staining bi-phasically ; the early increase was found along sinusoid from 6h to day 3 and the late increase was along fibers appeared in the necrotic area after day 4. Analyzes by northern blotting and in situ hybridization indicated that the late increase of chondroitinsulfate-PGs corresponded to the transcriptional increases of decorin and biglycan, both of which were the member of small chondroitinsulfate/dermatansulfate PGs. The early increase of chondroitinsulfate-PGs was indicated to correspond to the increase of unidentified proteoglycans with molecular weight of 163 kDa and 152 kDa that was identified by anti-DELTAdi antibodies. Such the transient increase of chondroitinsulfate proteoglycans may provide the environment efficient to allow the proliferation, since the mitosis requires cell detachment from the extracellular matrix.
While the transiently disappearing heparansulfate-PGs was found by northern blot analysis to be fibroglycan, one of membrane type heparansulfate PGs. It was found by others that fibroglycan was capable to bind hepatocyte growth factor, which was a strong mitogen of hepatocytes. Thus, the disappearance of fibroglycan at an early phase of acute liver injury may provide an environment efficient for the binding of HGF to c-Met, true receptor for HGF,which promote the mitogenic response during tissue repair.

  • Research Products

    (12 results)

All Other

All Publications (12 results)

  • [Publications] Koide N,et al.: "Small dermatan sulfate/chondroitin sulfate proteoglycans andhepatocyte spheroids." Tiss Cult Res Commun.11. 339-344 (1992)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Yumoto Y,et al.: "Treatment of hepatocellular carcinoma by transcatheter hepatic arterial injection of radioactive iodized oil solution." Cancer Chemotherapy and Pharmacology.31. 128-136 (1992)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Hada H,et al.: "Classification of hepatitis C virus into subgroups on the basis of sequence variations in the envelope protein," J Gasroenterology and Hepatology,. 8. 70-74 (1993)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ohkura T,et al.: "Increase of fucosylated serum cholinesterase in relation to high risk grop for hepatocellular carcinomas," Cancer Research. 54. 55-61 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Koede N,et al.: "Hepatocyte spheroid:differentiated features and potential utilization for the bioreactor or artificial liver support." Animal Cell Technology:Basic & Applied Aspects,. 6. 99-101 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Hirasaki S,et al.: "A Family with Hereditary Serum Cholinesterase Deficiency" Internal Medicine. (in press). (1995)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Koide N,et al: "Small dermatan sulfate/chondroitin sulfate proteoglycans and hepatocyte spheroids." Cancer Chemotherapy and Pharmacology. 31. S128-136 (1992)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yumoto Y,et al.: "Treatment of hepatocellular carcinoma by transcatheter hepatic arterial injection of radioactive iodized oil solution." Cancer Chemotherapy and Pharmacology. 31. S128-136 (1992)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Hada H,et al.: "Classification of hepatitis C virus into subgroups on the basis of sequence variations in the envelope protein" J Gasroenterology and Hepatology. 8. S70-74 (1993)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ohkura T,et al.: "Increase of fucosylated serum cholinesterase in relation to high risk group for hepatocellular carcinomas" Cancer Research. 54 (1). 55-61 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Koide N,et al: "Hepatocyte spheroid : differentiated features and potential utilization forthe bioreactor or artificial liver support." Animal Cell Technology : Basic & Applied Aspects. 6. 99-101 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Hirasaki S,et al.: "A family with hereditary serum cholinesterase deficiency" Internal Medicine. (in press). (1995)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 1996-04-15  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi